Forward Pharma A/S American Depositary Shares
FWP was delisted on the 27th of December, 2022.
1 hedge funds and large institutions have $300K invested in Forward Pharma A/S American Depositary Shares in 2023 Q2 according to their latest regulatory filings, with funds opening new positions, increasing their positions, 1 reducing their positions, and 0 closing their positions.
0% more funds holding
Funds holding: 1 → 1 (0)
7% less capital invested
Capital invested by funds: $323K → $300K (-$23K)
100% less repeat investments, than reductions
Existing positions increased: 0 | Existing positions reduced: 1
Top Buyers
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
MCM
Mason Capital Management
New York
|
-$85.5M |
FWP Hedge Fund Activity: Q2 2023 in Review
1 of the 6,369 institutional investors tracked by Wall St. Rank reported a position in Forward Pharma A/S American Depositary Shares (FWP) for Q2 2023, worth a combined $300K — down 7.1% from $323K a quarter earlier.
Fund positioning in FWP was balanced in Q2 2023: 0 funds opened new positions, 0 closed out, 0 added to existing stakes and 1 trimmed.
The largest seller was Mason Capital Management, cutting an estimated $85.5M.
- 1 institutional investor held Forward Pharma A/S American Depositary Shares (FWP) as of Q2 2023, unchanged from Q1 2023.
- Funds reported $300K of Forward Pharma A/S American Depositary Shares stock for Q2 2023, down 7.1% quarter-over-quarter.
- 0 funds opened new Forward Pharma A/S American Depositary Shares positions in Q2 2023 and 0 closed out.
- The largest Forward Pharma A/S American Depositary Shares seller in Q2 2023 was Mason Capital Management, an estimated $85.5M sold.
Based on aggregated 13F filings for Q2 2023.